|
||
|
||
Banyu, Maruho Receive NHI Approval for Oral Scabies Medication
Tokyo, Aug 25, 2006 (JCN) - Banyu Pharmaceutical and Maruho Co., Ltd. have announced that an additional indication of Stromectol Tablets 3mg - generic name ivermectin - has been approved for the administration for scabies treatment under the Nippon Health Insurance (NHI) system, alleviating patients' payment for the drug themselves.
Banyu retains approval for the manufacturing and marketing Stromectol in Japan, but has transfered sales rights to Maruho.
Stromectol joins with glutamatergic chloride ion channels, increasing the permeability of the cell membrane to chloride ions which kills parasites. Presently, no effective oral drug has been introduced to treat scabies, so the addition of oral drug Stromectol Tablets 3mg has been encouraged by the health sector in Japan. http://www.biospace.com/news_story.aspx?NewsEntityId=28510
Japan: "Stromectol" - Banyu Pharmaceutical Co. 2-3, Nihombashi-Honcho 2-Chome Chuo-ku Tokyo 103-8416 Japan Phone: 03-5203-8111 A wholly Owned Subsidiary Of Merck & Co., Inc. Global Headquarters www.Merck.com One Merck Drive P.O. Box 100
Whitehouse Station, NJ 08889-0100 USA Phone: 908-423-1000
Argentina: "Ivermectina" - Laboratorios Panalab S.A. Argentina Tel: (0800) 222-2666 (para Escabiosis humana) Over the counter, no prescription needed $15 for pkg of 6 tablets, 6mg each. www.PanaLab.com.ar Brand Name: "Ivertol" sold in 6mg tablets
Brazil: Ivermectina - Brand Name "Revectina" Manufacturer: Solvay Farma Ltda. R.Salvador Branco de Andrade, 93 Traboa de Serra - SP (0800-0141500) - pkg of 4 tablets, 6mg each $12 www.solvayfarma.com.br Mexico: Ivermectin/Mectizan www.Mectizan.org Donated by... Guess Who?? Merck in USA & GlaxoSmithKline (same people who make Kwellada-P sold in Canada without prescription) This website states that Merck has provided Stromectol for close to 250 million onchocerciasis treatments; it is estimated that more than 30 million people currently receive Mectizan annually for the treatment of this disease. Merck’s commercial version of Mectizan®, is approved for use in the US and is available commercially, however not approved by the FDA for use in the USA for Scabies. In Brazil, Argentina, Mexico, Japan, Africa, Australia, oral Ivermectin is labeled and prescribed for Scabies treatment when other treatments fail. (But generally not prescribed in the USA)